35 results about "Tuberculous pleurisy" patented technology

The invention discloses a Chinese medicinal pill preparation for treating tuberculosis pleuritis, peritonitis, empyema and broncho-pleural fistula, which is prepared from 26 kinds of Chinese medicinal herbs including notoginseng, lily bulb, Sichuan fritillary bulb, lepidium seed, selfheal and weeping forsythia through steps of disintegrating, sieving, mixing homogenously, making water pills, and drying at low temperature.

The invention relates to a traditional Chinese medicine composition for curing phthisis and tuberculous pleurisy. The composition provided by the invention is prepared from the following raw materials: 8-15g of American ginseng, 5-8g of ginseng, 20-30g of radix astragali, 5-8g of pearls, 5-7g of walnuts, 20-30g of herba epimedii, 5-7g of toad oil, 2-3g of Chinese caterpillar fungus, 15-25g of flax, 5-10g of hide glue, 20-30g of mulberry, 10-20g of lilium brownie, 5-15g of burdock and 2-3g of multifloral honey. The traditional Chinese medicine composition can rapidly enhance the functions of four immune systems, and has the efficacies of dispersing lung Qi and supplementing vitality, moistening the lung for arresting cough, regulating blood and qi circulation, enriching blood and qi, dispelling melancholy and soothing chest, reinforcing sufficiency of fiver organs, tonifying vitality of six spleens, restoring qi, and preventing and curing diseases. After the composition is taken, the clinical symptoms of phthisis can be rapidly alleviated, the composition becomes effective within 5-15 days, one month is a treatment course, phthisis patients can be cured after 2-3 treatment courses generally, and the treatment effect is preferable for phthisis drug resistant persons.

The invention discloses a reagent box for detection or auxiliary detection of tuberculous pleurisy and belongs to the technical field of detection of the tuberculous pleurisy. The reagent box includes a box body. A box cover is installed on the top of the box body. A handle is disposed in the center of the top of the box cover. A temperature sensor is installed on the bottom of a bottom board. A separation board is installed on the top of the bottom board. A specification book placing groove is formed in the right side of an inner chamber in the bottom board. A plurality of reagent placing slots are formed in the bottom board uniformly. The temperature sensor is used for detecting the temperature in the reagent box, when the temperature is excessively high, a controller controls a refrigerating apparatus for performing refrigeration, thereby ensuring stability of storage temperature of the tuberculous pleurisy reagents and prolonging the preservation time of the tuberculous pleurisy reagents. By arranging the grooves around the reagent placing slots, the reagents are convenient to take and store. The reagent box is convenient to use, and can be used for auxiliary detection of the tuberculous pleurisy well.

The invention relates to a Chinese medicine composition for treating tuberculous pleurisy. The composition is prepared from the following Chinese medicines, by weight: 3 to 25 parts of ardisia japonica herbs, 3 to 20 parts of veronicastrum herbs, 3 to 20 parts of sweetgum fruits, 3 to 20 parts of selfheal spikes, 3 to 20 parts of houttuynia herbs, 3 to 20 parts of bletilla rhizomes, and 3 to 9 parts of licorice roots. The composition is a substitute for hormone medicines to reduce swelling and cure tuberculous pleural effusion. The composition has effects of dispelling wind, eliminating dampness, soothing the liver, invigorating the collaterals, and promoting dieresis, has some inhibition effect on mycobacterium tuberculosis, has an astringent effect on a tuberculous focus, can reduce fluid exudation at the tuberculous focus, and promotes circulation in lymphatic vessels, so that interstitial fluid is rapidly removed and absorbed. If the composition is orally taken and combined with anti-tuberculosis drugs to treat the tuberculous pleurisy, the effective rate and the cure rate are 100% and 98.7% respectively; it takes no more than 30 days to remove effusion; a whole treatment takes no more than 12 months; no significant toxic and side effects are observed; and there is no damage to liver, kidney, and stomach functions.

The invention relates to a traditional Chinese medicine composition for curing phthisis and tuberculous pleurisy. The composition provided by the invention is prepared from the following raw materials: 8-15g of American ginseng, 5-8g of ginseng, 20-30g of radix astragali, 5-8g of pearls, 5-7g of walnuts, 20-30g of herba epimedii, 5-7g of toad oil, 2-3g of Chinese caterpillar fungus, 15-25g of flax, 5-10g of hide glue, 20-30g of mulberry, 10-20g of lilium brownie, 5-15g of burdock and 2-3g of multifloral honey. The traditional Chinese medicine composition can rapidly enhance the functions of four immune systems, and has the efficacies of dispersing lung Qi and supplementing vitality, moistening the lung for arresting cough, regulating blood and qi circulation, enriching blood and qi, dispelling melancholy and soothing chest, reinforcing sufficiency of fiver organs, tonifying vitality of six spleens, restoring qi, and preventing and curing diseases. After the composition is taken, the clinical symptoms of phthisis can be rapidly alleviated, the composition becomes effective within 5-15 days, one month is a treatment course, phthisis patients can be cured after 2-3 treatment courses generally, and the treatment effect is preferable for phthisis drug resistant persons.

The invention relates to a traditional Chinese medicine composition for treating pulmonary tuberculosis, which comprises the following components of lilium brownie, ladybell root, lilyturf root, rehmannia, ginseng, cortex lycii, bulbus fritillariae cirrhosae, radix stemonae,common bletilla pseudobulb, radix astragali, Chinese yam and radix ranunculi ternati. The traditional Chinese medicine composition has the effect of nourishing yin for moistening lung, replenishing qi and invigorating the spleen, and can be used for preparing a medicine for preventing and treating pulmonary tuberculosis and / or lymph gland tuberculosis and / or tuberculous pleurisy. The invention also relates to a preparation method of the traditional Chinese medicine composition, which adopts different extraction methods according to the medicine properties of different herbal medicines to extract effective components in the herbal medicines maximally, thus enhancing medicine effect.

The invention discloses a kit for detection or assisted detection of tuberculous pleurisy. The kit comprises a device for detecting the expression amount of an immune factor, wherein the immune factor comprises (1) IL-6, IL-13, G-CSF, CCL1, CCL21, IP-10 (CXCL10), CCL8 (MCP-2), CXCL9 (MIG) and CXCL12 (SDF-1); or (2) at least one of IL-6, IL-13, G-CSF, CCL1, CCL21, IP-10 (CXCL10), CCL8 (MCP-2), CXCL9 (MIG) and CXCL12 (SDF-1). Experiments prove that a method for specifically identifying tuberculous pleurisy by taking hydrothorax as a detection object, utilizing a group of immunologic molecular marker, and adopting a multiple-factor microsphere detection technique is developed, and the purposes of improving the disease diagnosis accuracy rate, scientifically judging the state of illness and the like are realized by a multiple-factor combination manner.

The invention relates to an anti-tuberculosis Chinese medicine, a special adjuvant medicine and a preparation method thereof. Pharmaceutically-effective raw materials of the anti-tuberculosis Chinese medicine comprise blister beetle, drgon's bone, oyster, chicken gizzard-membrane, pumice and egg white of 10 eggs (yolk removed). The adjuvant medicine is water soaking liquid or water decoction of one or more selected from milkvetch root, licorice root, ginseng, radix codonopsis, milkvetch root, red jujube and wine-processed twotoothed achyranthes root. The medicine has the effects of removing blood stagnation and eliminating pathogenic accumulation, and is mainly used to treat pulmonary tuberculosis, tuberculous pleurisy, pyogenic osteomyelitis, bone tuberculosis, tuberculosis of thoracic and lumbar vertebra, lymphoid tuberculosis, tuberculous peritonitis, silicosis complicated with tuberculosis, and acute lymphadenitis.

The invention relates to a traditional Chinese medicine composition for treating pulmonary tuberculosis, which comprises the following components of lilium brownie, ladybell root, lilyturf root, rehmannia, ginseng, cortex lycii, bulbus fritillariae cirrhosae, radix stemonae,common bletilla pseudobulb, radix astragali, Chinese yam and radix ranunculi ternati. The traditional Chinese medicine composition has the effect of nourishing yin for moistening lung, replenishing qi and invigorating the spleen, and can be used for preparing a medicine for preventing and treating pulmonary tuberculosis and / or lymph gland tuberculosis and / or tuberculous pleurisy. The invention also relates to a preparation method of the traditional Chinese medicine composition, which adopts different extraction methodsaccording to the medicine properties of different herbal medicines to extract effective components in the herbal medicines maximally, thus enhancing medicine effect.

The invention relates to a hydrothorax exosome metabolite combination, a kit and a method for diagnosing tuberculous pleurisy. The hydrothorax exosome metabolite combination for diagnosing the tuberculous pleurisy is prepared from dimethylglycine, choline, acyl carnitine with the ratio of 10: 2, phosphatidylcholine with the ratio of 35: 6, phosphatidylcholine o with the ratio of -36: 0, phosphatidylethanolamine with the ratio of 33: 2, sphingomyelin with the ratio of 28: 1 and oleic acid. The kit for diagnosing the tuberculous pleurisy comprises an internal standard substance required for detecting the concentration of the metabolites in the hydrothorax exosome sample extraction solution. A combined marker provided by the invention has the characteristics of high sensitivity and high specificity for the diagnosis of tuberculous pleurisy, and meanwhile, can be complementary with the traditional marker adenosine deaminase, and can be used for the auxiliary diagnosis of the tuberculous pleurisy by being combined with the traditional marker adenosine deaminase.

The invention relates to a hydrothorax microparticle metabolite combination, a kit and a method for diagnosing tuberculous pleurisy. The pleural effusion microparticle metabolite composition for diagnosing tuberculous pleurisy comprises phenylalanine, tyrosine, methionine, kynurenine, lauroyl carnitine, glycine-binding chenodeoxycholic acid, phosphatidylcholine with the ratio of 36: 7 and lysophosphatidylcholine with the ratio of 20: 2. The kit for diagnosing tuberculous pleurisy comprises an internal standard substance for detecting the concentration of metabolites in the pleural effusion microparticle sample extraction solution. A combined marker provided by the invention has the characteristics of high sensitivity and high specificity for the diagnosis of tuberculous pleurisy, at the same time, can be complementary with a traditional marker adenosine deaminase, and can be used for the auxiliary diagnosis of the tuberculous pleurisy by being combined with the traditional marker adenosine deaminase.

The invention relates to a medicine for treating tuberculous pleurisy and in particular relates to a traditional Chinese medicine composition which is prepared by using Chinese herbal medicines as raw materials and is used for treating tuberculous pleurisy. The traditional Chinese medicine composition is characterized by comprising the following active pharmaceutical ingredients by weight: 10-14g of radix adenophorae, 10-14g of Indian bread, 10-14g of platycodon root, 9-13g of pollens and 7-9g of ephedra. According to the dialectic theory of the traditional Chinese medicine, the traditional Chinese medicine composition has simple components, is accessible in materials and low in cost, has good curative effects and does not have any toxic or side effect. With the functions of regulating qi-flowing to dredge collaterals, reducing phlegm and activating blood and nourishing yin and clearing heat, the traditional Chinese medicine composition has curative effects on patients, has broad-spectrum practicability and can be used for effectively treating tuberculous pleurisy.

The invention discloses a medicine composition for treating tuberculous pleurisy, a method for preparing the medicine composition and application thereof. The medicine composition comprises, by weight, 1-3 parts of artemisinin, 3-7 parts of cyproheptadine, 15-23 parts of taurine and 11-19 parts of cefuroxime. The method includes mixing and grinding the cyproheptadine and the cefuroxime with each other, adding deionized water into the cyproheptadine and the cefuroxime and stirring and treating the deionized water, the cyproheptadine and the cefuroxime at the temperature of 66 DEG C for 48-50 min to obtain mixtures A; mixing the taurine and the mixtures A with one another, stirring and treating the taurine and the mixtures A at the temperature of 60 DEG C for 23-25 min, adding the artemisinin into the taurine and the mixtures A to obtain other mixtures, carrying out ultrasonic treatment on the other mixtures at the temperature of 43 DEG C for 33 min, then stirring the other mixtures at the temperature of 55 DEG C until the other mixtures are dried and granulating the other mixtures to obtain the medicine composition. The medicine composition, the method and the application have the advantages that the medicine composition can be used for treating the tuberculous pleurisy, is high in cure rate, short in treatment time, free of toxic and side effects or allergic reaction and low in manufacturing cost and dosage, can become effective fast and is a perfect medicine, obvious treatment effects can be realized, and the tuberculous pleurisy is low in recurrence rate.

The invention relates to a hydrothorax fluid metabolite combination, a kit and a method for diagnosing tuberculous pleurisy. The hydrothorax fluid metabolite combination for diagnosing tuberculous pleurisy comprises dimethylglycine, tyrosine, kynurenine, nicotinamide, betaine, acylcarnitine with the ratio of 12: 0, acylcarnitine with the ratio of 14: 2 and phosphatidylcholine with the ratio of 42:8. The kit for diagnosing tuberculous pleurisy comprises an internal standard substance required for detecting the concentrations of dimethylglycine, tyrosine, kynurenine, nicotinamide, betaine, acylcarnitine with the ratio of 12: 0, acylcarnitine with the ratio of 14: 2 and phosphatidylcholine with the ratio of 42: 8 in a pleural effusion sample extraction solution. A combined marker provided bythe invention has the characteristics of high sensitivity and high specificity for the diagnosis of tuberculous pleurisy, meanwhile, can be complementary with the traditional marker adenosine deaminase, and can be used for the auxiliary diagnosis of the tuberculous pleurisy by being combined with the traditional marker adenosine deaminase.

The invention discloses a traditional Chinese medicine composition for treating tuberculous pleurisy. The traditional Chinese medicine composition is characterized by comprising, by weight, 10-30 parts of Mongolian milkvetch roots, 10-20 parts of nutgrass galingale rhizomes, 10-20 parts of incisory spleenwort herb, 5-15 parts of English walnut, 10-20 parts of fragrant solomonseal rhizomes, 5-15 parts of great burdock fruits, 10-20 parts of rhizome of lalang grass rhizomes, 10-20 parts of prepared rehmannia roots, 10-20 parts of Chinese hibiscus flowers, 5-15 parts of common bletilla tubers, 10-20 parts of common dayflower herb, 10-20 parts of sessile stemona roots, 10-20 parts of notoginseng roots, 5-15 parts of tanakaea omeiensis, 10-20 parts of agaric, 10-20 parts of paper mulberry fruits, 10-20 parts of Japanese ardisia stems and leaves, 10-20 parts of dahurian rose fruits, 10-20 parts of earthworm, 10-20 parts of fructus trichosanthis, 5-15 parts of Chinese corktree barks, 10-20 parts of clam shells and 5-15 parts of ural licorice roots. The traditional Chinese medicine composition has the functions of regulating qi, activating blood, resolving dampness and eliminating phlegm and is scientific in compatibility, remarkable in curative effect, reliable in action and free from side effect.

The invention discloses a kit for detection or assisted detection of tuberculous pleurisy. The kit comprises a device for detecting the expression amount of an immune factor, wherein the immune factor comprises (1) IL-6, IL-13, G-CSF, CCL1, CCL21, IP-10 (CXCL10), CCL8 (MCP-2), CXCL9 (MIG) and CXCL12 (SDF-1); or (2) at least one of IL-6, IL-13, G-CSF, CCL1, CCL21, IP-10 (CXCL10), CCL8 (MCP-2), CXCL9 (MIG) and CXCL12 (SDF-1). Experiments prove that a method for specifically identifying tuberculous pleurisy by taking hydrothorax as a detection object, utilizing a group of immunologic molecular marker, and adopting a multiple-factor microsphere detection technique is developed, and the purposes of improving the disease diagnosis accuracy rate, scientifically judging the state of illness and the like are realized by a multiple-factor combination manner.

The present invention relates to a pleural effusion metabolite combination, a kit and a method for diagnosing tuberculous pleurisy, the pleural effusion metabolite combination for diagnosing tuberculous pleurisy comprising dimethylglycine, tyrosine, kynurenine, and nicotinamide , betaine, acylcarnitine 12:0, acylcarnitine 14:2 and phosphatidylcholine 42:8. Kit for the diagnosis of tuberculous pleurisy, including for the detection of dimethylglycine, tyrosine, kynurenine, nicotinamide, betaine, acylcarnitine 12:0, acylcarnitine 14 in the extraction solution of pleural fluid samples :2 and Phosphatidylcholine 42:8 are the required internal standards. Through the combined markers involved in the present invention, the diagnosis of tuberculous pleurisy can be characterized with high sensitivity and high specificity. At the same time, the combined marker can be complementary to the traditional marker adenosine deaminase, and combined use can be used for auxiliary diagnosis of tuberculous pleurisy.

The invention relates to a traditional Chinese medicinal composition for treating tuberculous pleurisy. The traditional Chinese medicinal composition consists of the following traditional Chinese medicinal raw materials in parts by weight: 10-30 parts of radix codonopsis, 5-25 parts of herba epimedii, 5-25 parts of littleleaf indianmulberry herb, 5-20 parts of szechwan Chinaberry fruits, 5-25 parts of veronicastrum herb, 5-25 parts of herba aristolochiae, 5-25 parts of beautiful sweetgum fruits, 5-20 parts of flos carthami, 5-25 parts of henry clematis root, 5-25 parts of rhizoma curculiginis, 5-25 parts of rhizoma of ophiopogon tonkinensis, 5-20 parts of semen pharbitidis, 5-25 parts of herb of aernaria przewalskii maxim, 5-25 parts of marginate American agave leaf, 5-20 parts of common sowthistle herb, 5-25 parts of cudrania cochinchinensis kudo et masam, 5-25 parts of apricot kernels, 5-20 parts of rhizoma polygoni cuspidati, 5-25 parts of herb of bulbophyllum levinei schltr, 5-25 parts of anderson cirrhopetalum herb, 5-20 parts of pericarpium arecae, 5-25 parts of herba achyranthis asperae and 5-15 parts of liquorice root. The traditional Chinese medicinal composition provided by the invention has functions of tonifying spleen and lung, soothing liver and purging heat, reducing phlegm and removing fluid, promoting circulation of qi and blood, dredging collaterals and alleviating pain, and relieving stranguria by diuresis; and the traditional Chinese medicinal composition, on treating the tuberculous pleurisy, is significant in curative effect and reliable in action.

The invention discloses a real-time fluorescent quantitative PCR kit for assisting in the diagnosis of tuberculous pleurisy and its application. The kit contains primers and probes for detecting Mycobacterium tuberculosis specific small RNA fragments (comprising Mtb-ms-1 and Mtb-ms-2), wherein the sequence of Mtb-ms-1 is as SEQ ID NO.1 As shown, the sequence of Mtb-ms-2 is shown in SEQ ID NO.2. The present invention extracts the total RNA of a small amount of pleural effusion of patients with pleurisy, reverse-transcribes the specific small RNA fragment of Mycobacterium tuberculosis into complementary cDNA, and uses specific primer probes for real-time fluorescent quantitative polymerase chain reaction detection, and its diagnostic sensitivity and specificity The results were high, able to significantly distinguish tuberculous pleurisy from the control group, superior to other diagnostic methods such as Mycobacterium tuberculosis culture, acid-fast smear staining, and DNA testing.

The invention discloses a dye method digital quantitative PCR kit and its application and usage method. Including the application of the circular RNA hsa_circ_0051778 copy number as a detection indicator in the differentiation kit between lung adenocarcinoma and tuberculous pleurisy, according to the copy number of circular RNA hsa_circ_0051778 in tuberculous pleurisy is higher than that in lung adenocarcinoma; Among them, the kit includes circular RNA hsa_circ_0051778-specific primers, positive control, negative control, PCR amplification premix for dye-based digital PCR and sterile deionized water; through sampling, PCR amplification system preparation, amplification reaction and identification Steps to use this kit. Therefore, it can accurately and quickly identify lung adenocarcinoma and tuberculous pleurisy. The detection results show that the sensitivity of this detection tool can reach more than 90%, which is higher than the single method currently used clinically.

The invention discloses a reagent kit for detecting tuberculous pleurisy, provides a reagent kit for detecting whether mycobacterium tuberculosis exists in hydrothorax, and relates to a recovery factor protein composition containing a 7H11 solid culture medium and the mycobacterium tuberculosis. The recovery factor protein composition consists of at least two of RpfA protein, RpfB protein, RpfC protein, RpfD protein and RpfE protein, wherein the mol parts of the proteins conforms to the following standard: 0-156 parts of the RpfA protein, 0-173 parts of the RpfB protein, 0-473 parts of the RpfC protein, 0-150 parts of the RpfD protein, and 0-121 parts of the RpfE protein. Experiment proves that the reagent kit for detecting mycobacterium tuberculosis in hydrothorax has the characteristicsof being short in positive report time, high in positive rate, and high in formation unit number of positive colonies. The reagent kit has important significance in detection or auxiliary detection ofthe tuberculous pleurisy.

Tuberculous pleurisy treatment equipment disclosed in the invention comprises a liquid extraction mechanism, and supporting legs are fixedly connected to the four corners of the bottom end of the liquid extraction mechanism; and a bottom plate is arranged at the bottom end of the liquid extraction mechanism, the bottom plate can be placed at the liquid extraction position of a patient, fixing plates are evenly arranged on the periphery of the bottom plate, and the bottom plate can be fixedly connected to the liquid extraction position of the patient, so follow-up liquid extraction work is facilitated; a puncture needle is arranged at the bottom end of the liquid extraction mechanism, so follow-up puncture work is facilitated; and a motor is fixedly connected to the inner side of the liquid extraction mechanism, a first gear is fixedly connected to the output end of the motor, a second gear is connected to the first gear in a meshed mode, a connecting rod is fixedly connected to one side of the second gear, and puncture needles are fixedly connected to the two sides of the connecting rod, so the puncturing motion is slow and precise, and the doctor can conveniently do puncturing motion. The equipment is simple in structure and convenient to operate, and the working efficiency of the doctor is greatly improved.

The invention relates to an external traditional Chinese medicine for treating tuberculous pleurisy with introduction of magnetic heat and belongs to an external traditional Chinese medicine. The external traditional Chinese medicine is prepared from the following crude drugs in parts by weight: 50-100 parts of radix aconite, 50-100 parts of radix aconiti kusnezoffii, 20-30 parts of asarum, 50-80 parts of rhizoma alismatis, 50-100 parts of cassia twig, 50-100 parts of ligusticum wallichii, 30-60 parts of pseudo-ginseng, 30-50 parts of scorpio, 20-30 parts of safflower, 20-30 parts of mirabilite and 15-30 parts of semen strychni. Compared with the prior art, the external traditional Chinese medicine has the advantages of no toxic or side effect, good and rapid treating effect, low cost, convenient administration and the like.

The invention relates to the technical field of medicines, in particular to a molecular marker composition for diagnosing tuberculous pleurisy and application of the molecular marker composition. The molecular marker composition is a composition of miR-4455 (micro Ribonucleic Acid), miR-574-5p (micro Ribonucleic Acid) and miR-4701-3p (micro Ribonucleic Acid). The molecular marker composition is used for preparing a diagnostic reagent or kit for tuberculous pleurisy. According to the invention, a high-throughput microarray chip is used for identifying pleural effusion differential miRNA for distinguishing tuberculous pleurisy and malignant pleural diseases for the first time, and further verification is carried out in an independent sample. The invention provides and identifies the miRNA composition which can be used for identifying and diagnosing focus parts of tuberculous pleurisy and malignant pleural diseases, and the miRNA composition is very important for improving the diagnosis of the tuberculous pleurisy.

The invention relates to a traditional Chinese medicine for treating tuberculous pleurisy, which is prepared from the following medicinal materials in proportion by weight: 14 parts of sage mulberry, 16 parts of fenxinmu, 15 parts of cypress leaves, 10 parts of chrysanthemum chrysanthemum, 14 parts of fragrant green stems, 12 parts of Dajiugu cattle, 15 parts of Daxiangfuzi, 18 parts of Eping grass, 12 parts of snow tea, 15 parts of Fuzhuo wood bark, 12 parts of a grass, 16 parts of Northeast alder, multi-flower 20 parts of step grass, 14 parts of Didihua, 10 parts of gallinaceous gizzard, 14 parts of Pyramid fern, 10 parts of Rhododendron japonica, 8 parts of bergamot, 16 parts of cypress bottom. Clinical experiments prove that the present invention can safely and effectively treat tuberculous pleurisy.

The invention relates to the technical field of medicines, in particular to a molecular marker for diagnosing tuberculous pleurisy and application of the molecular marker. The molecular marker is miR-4455 (micro Ribonucleic Acid) or miR-574-5p (micro Ribonucleic Acid) or miR-4701-3p (micro Ribonucleic Acid). The molecular marker is used for preparing a diagnostic reagent or kit for tuberculous pleurisy. The method has the advantages that (1) the identification effect is good; (2) the sensitivity is high; and (3) the specificity is high. And (4) the method is suitable for diagnosis and has high accuracy.

The invention relates to a Chinese medicine composition for treating tuberculous pleurisy. The composition is prepared from the following Chinese medicines, by weight: 3 to 25 parts of ardisia japonica herbs, 3 to 20 parts of veronicastrum herbs, 3 to 20 parts of sweetgum fruits, 3 to 20 parts of selfheal spikes, 3 to 20 parts of houttuynia herbs, 3 to 20 parts of bletilla rhizomes, and 3 to 9 parts of licorice roots. The composition is a substitute for hormone medicines to reduce swelling and cure tuberculous pleural effusion. The composition has effects of dispelling wind, eliminating dampness, soothing the liver, invigorating the collaterals, and promoting dieresis, has some inhibition effect on mycobacterium tuberculosis, has an astringent effect on a tuberculous focus, can reduce fluid exudation at the tuberculous focus, and promotes circulation in lymphatic vessels, so that interstitial fluid is rapidly removed and absorbed. If the composition is orally taken and combined with anti-tuberculosis drugs to treat the tuberculous pleurisy, the effective rate and the cure rate are 100% and 98.7% respectively; it takes no more than 30 days to remove effusion; a whole treatment takes no more than 12 months; no significant toxic and side effects are observed; and there is no damage to liver, kidney, and stomach functions.